Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "User talk:Beno Marija/MitO2 Kit Produktseite"

From Bioblast
 
(19 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{Product
{{Product
|description= Cell permeable compound - MitO2-Kit, 2 vials; for a final volume of 35 mg (25mg NVP118 + 10mg NVP161)
|description=Cell permeable compound - Mito-CII-Kit, 2 vials; 1 vial of NV118 (25 mg) + 1 vial of NV161 (10 mg)
|product id= (##)
|product id=60200-01
|product type=O2k
|product type=O2k
|info=[[NVP118]], [[NVP161]]
|info=[[Image:MitoPedia.jpg|left|60px|link=http://www.bioblast.at/index.php/MitoPedia:_DatLab |MitoPedia: Mito-CII]] [[MitoPedia: Mito-CII]]
|product image=[[Image:MiR05-Kit label.png|right|180px]]
|product image=  
}}
}}
__TOC__
__TOC__
Compounds  
Compounds  


== Cell permeable compound - MitO2-Kit ==
== Cell permeable compounds NV118 and NV161 - Mito-CII-Kit ==
 
=== Preparation ===
 
::::* The prodrug NV118 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.
::::* The prodrug NV161 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.
 
 
{{Publication
{{Publication
|title=[[Image:O2k-Protocols.jpg|right|80px|link=http://wiki.oroboros.at/index.php/O2k-Protocols|O2k-Protocols]] Cell permeable compound - MitO2-Kit.  
|title=[[Image:O2k-Protocols.jpg|right|80px|link=http://wiki.oroboros.at/index.php/O2k-Protocols|O2k-Protocols]] Cell permeable compound - Mito-CII-Kit.  
|info=[[File:PDF.jpg|100px|link=http://wiki.oroboros.at/images/c/c8/MiPNet22.10_MiR05-Kit.pdf |Bioblast pdf]] » [http://wiki.oroboros.at/index.php/File:MiPNet22.10_MiR05-Kit.pdf Versions]
|info=[[File:PDF.jpg|100px|link=http://wiki.oroboros.at/images/c/c8/MiPNet22.10_MiR05-Kit.pdf |Bioblast pdf]] » [http://wiki.oroboros.at/index.php/File:MiPNet22.10_MiR05-Kit.pdf Versions]
|authors=Oroboros
|authors=Oroboros
|year=2019-03-01
|year=2019-03-01
|journal=Mitochondr Physiol Network
|journal=Mitochondr Physiol Network
|abstract=Gnaiger E, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - MitO2-Kit. Mitochondr Physiol Network 24.03(01):1-2.  
|abstract=Gnaiger E, Bastos A, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - Mito-CII-Kit. Mitochondr Physiol Network 24.03(01):1-2.  


(##) The cell permeable compound MitO2-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease.  
(##) The cell permeable compound Mito-CII-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease.  
:» Product: [[Oroboros O2k]], [[Oroboros O2k-Catalogue | O2k-Catalogue]]
:» Product: [[Oroboros O2k]], [[Oroboros O2k-Catalogue | O2k-Catalogue]]
|keywords=Mit02-Kit
|keywords=Mito-CII-Kit
|mipnetlab=AT_Innsbruck_Oroboros, NeuroVive
|mipnetlab=AT_Innsbruck_Oroboros, NeuroVive
}}
}}




== Compounds of MitO2-Kit ==
== Compounds of Mito-CII-Kit ==
:::: The MitO2-Kit is composed of equal quantities of the following Compounds:
:::: The Mito-CII-Kit is composed of equal quantities of the following Compounds:


::::* '''[[NVP118]]'''
::::* '''Cell permeable compound [[NV118]]'''
::::: Description: Succinate prodrug: C<sub>10</sub>H<sub>14</sub>O<sub>8</sub>, Molecular weight 262,2g.mol<sup>-1</sup>
::::: Description: Succinate prodrug: C<sub>10</sub>H<sub>14</sub>O<sub>8</sub>, Molecular weight 262,2g.mol<sup>-1</sup>
::::: Aliquots per 25 mg
::::: Aliquots per 25 mg




::::* '''[[NVP161]]'''
::::* '''Cell permeable compound [[NV161]]'''


::::: Description: Malonate prodrug: C<sub>9</sub>H<sub>12</sub>O<sub>8</sub>, Molecular weight 248,2g.mol<sup>-1</sup>
::::: Description: Malonate prodrug: C<sub>9</sub>H<sub>12</sub>O<sub>8</sub>, Molecular weight 248,2g.mol<sup>-1</sup>
Line 40: Line 47:


::::* Reference:
::::* Reference:
:::::: Ehinger JK, Piel S, Ford R, Karlsson M, Sjövall F, Frostner EÅ, Morota S, Taylor RW, Turnbull DM, Cornell C, Moss SJ, Metzsch C, Hansson MJ, Fliri H, Elmér E (2016) Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun 7:12317. [[Ehinger 2016 Nat Commun|»Bioblast link«]] - Original publication introducing MitO2.
:::::: Ehinger JK, Piel S, Ford R, Karlsson M, Sjövall F, Frostner EÅ, Morota S, Taylor RW, Turnbull DM, Cornell C, Moss SJ, Metzsch C, Hansson MJ, Fliri H, Elmér E (2016) Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun 7:12317. [[Ehinger 2016 Nat Commun|»Bioblast link«]] - Original publication introducing Mito-CII.
 
 
== Expiry date of Mito-CII-Kit compounds (according to NeuroVive) ==
 
 
Before preparation:
::::* 3 years in -80° C
::::* 1 year in -20° C




== Expiry date of MitO2==
Prepared:
::::* In DMSO solution
::::::* at room temperature: 24 hours.
::::::* at -20° C: for weeks


::::# The stability of compounds in DMSO solution at room temperature is for at least 24h. The estimated stability of the compounds in DMSO at -20 would be weeks. The aliquoted 118 and 161 are stable at -20 for 6 months+. The powder is likely stable for much longer.


::::* CAS-Number 1592635-33-0 for NV-118
CAS-Numbers:
::::* CAS-Number 1432752-62-9 for NV-161
::::* NV-118: 1592635-33-0  
::::* NV-161: 1432752-62-9  





Latest revision as of 13:16, 22 March 2019

                



User talk:Beno Marija/MitO2 Kit Produktseite

O2k-Catalogue

Description Cell permeable compound - Mito-CII-Kit, 2 vials; 1 vial of NV118 (25 mg) + 1 vial of NV161 (10 mg)
Product ID 60200-01
Type O2k
Link
MitoPedia: Mito-CII
MitoPedia: Mito-CII
Image

Compounds

Cell permeable compounds NV118 and NV161 - Mito-CII-Kit

Preparation

  • The prodrug NV118 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.
  • The prodrug NV161 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.


Publications in the MiPMap
O2k-Protocols
Cell permeable compound - Mito-CII-Kit.

» Bioblast pdf » Versions

Oroboros (2019-03-01) Mitochondr Physiol Network

Abstract: Gnaiger E, Bastos A, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - Mito-CII-Kit. Mitochondr Physiol Network 24.03(01):1-2.

(##) The cell permeable compound Mito-CII-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease.

» Product: Oroboros O2k, O2k-Catalogue

Keywords: Mito-CII-Kit

O2k-Network Lab: AT_Innsbruck_Oroboros, NeuroVive


Compounds of Mito-CII-Kit

The Mito-CII-Kit is composed of equal quantities of the following Compounds:
  • Cell permeable compound NV118
Description: Succinate prodrug: C10H14O8, Molecular weight 262,2g.mol-1
Aliquots per 25 mg


  • Cell permeable compound NV161
Description: Malonate prodrug: C9H12O8, Molecular weight 248,2g.mol-1
Aliquots per 10 mg


  • Reference:
Ehinger JK, Piel S, Ford R, Karlsson M, Sjövall F, Frostner EÅ, Morota S, Taylor RW, Turnbull DM, Cornell C, Moss SJ, Metzsch C, Hansson MJ, Fliri H, Elmér E (2016) Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun 7:12317. »Bioblast link« - Original publication introducing Mito-CII.


Expiry date of Mito-CII-Kit compounds (according to NeuroVive)

Before preparation:

  • 3 years in -80° C
  • 1 year in -20° C


Prepared:

  • In DMSO solution
  • at room temperature: 24 hours.
  • at -20° C: for weeks


CAS-Numbers:

  • NV-118: 1592635-33-0
  • NV-161: 1432752-62-9


Labels: MiParea: Instruments;methods 





HRR: O2k-Protocol 

O2k-chemicals and media